Log In
Print
BCIQ
Print
Print this Print this
 

2A2

  Manage Alerts
Collapse Summary General Information
Company PxRadia Inc.
DescriptionHumanized mAb targeting ceramide molecules in the cell membrane
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Gastrointestinal (unspecified)
Indication DetailsTreat gastrointestinal (GI) syndrome associated with acute radiation syndrome (ARS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today